Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients
Kevin Kalinsky(Emory University), Farideh Z. Bischoff(Biopeptide (United States)), Tony J. Pircher(Biopeptide (United States)), Xinyu Xu(Columbia University), Tam Pham(Biopeptide (United States)), JA Mayer(Biopeptide (United States)), Mindy A. Brown(Columbia University), Eligie Villarin(Biopeptide (United States)), Matthew Maurer(Columbia University), Ka Lam Wong(Biopeptide (United States))
Cited by 55
Related Papers
Current Landscape of Immunotherapy in Breast Cancer
|JAMA Oncology|2019|409
AKT in cancer: new molecular insights and advances in drug development
|British Journal of Clinical Pharmacology|2016|267
Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood
|Journal of Oncology|2011|256
Inavolisib-Based Therapy in <i>PIK3CA</i> -Mutated Advanced Breast Cancer
|New England Journal of Medicine|2024|235
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update
|Journal of Clinical Oncology|2022|127